nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—TNFSF11—tongue—salivary gland cancer	0.189	0.244	CbGeAlD
Lenalidomide—TNFSF11—connective tissue—salivary gland cancer	0.0777	0.101	CbGeAlD
Lenalidomide—CDH5—parotid gland—salivary gland cancer	0.0664	0.0861	CbGeAlD
Lenalidomide—CDH5—connective tissue—salivary gland cancer	0.0585	0.0757	CbGeAlD
Lenalidomide—TNFSF11—lymphoid tissue—salivary gland cancer	0.0568	0.0736	CbGeAlD
Lenalidomide—CDH5—epithelium—salivary gland cancer	0.0555	0.0719	CbGeAlD
Lenalidomide—CDH5—lymphoid tissue—salivary gland cancer	0.0427	0.0554	CbGeAlD
Lenalidomide—CRBN—parotid gland—salivary gland cancer	0.0422	0.0547	CbGeAlD
Lenalidomide—CRBN—saliva-secreting gland—salivary gland cancer	0.0404	0.0524	CbGeAlD
Lenalidomide—CDH5—Cell-Cell communication—MAGI2—salivary gland cancer	0.0353	0.155	CbGpPWpGaD
Lenalidomide—TNFSF11—lymph node—salivary gland cancer	0.0321	0.0415	CbGeAlD
Lenalidomide—CRBN—lymphoid tissue—salivary gland cancer	0.0272	0.0352	CbGeAlD
Lenalidomide—CDH5—lymph node—salivary gland cancer	0.0241	0.0312	CbGeAlD
Lenalidomide—CDH5—Cell junction organization—ITGB4—salivary gland cancer	0.0193	0.0848	CbGpPWpGaD
Lenalidomide—CRBN—lymph node—salivary gland cancer	0.0153	0.0199	CbGeAlD
Lenalidomide—CDH5—Cell-Cell communication—ITGB4—salivary gland cancer	0.0138	0.0603	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—NOTCH1—salivary gland cancer	0.0122	0.0534	CbGpPWpGaD
Lenalidomide—CDH5—Adherens junctions interactions—CDH1—salivary gland cancer	0.0121	0.053	CbGpPWpGaD
Lenalidomide—PTGS2—connective tissue—salivary gland cancer	0.0101	0.0131	CbGeAlD
Lenalidomide—PTGS2—epithelium—salivary gland cancer	0.0096	0.0124	CbGeAlD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—MAP2K2—salivary gland cancer	0.00853	0.0374	CbGpPWpGaD
Lenalidomide—PTGS2—lymphoid tissue—salivary gland cancer	0.00739	0.00958	CbGeAlD
Lenalidomide—CDH5—Cell-cell junction organization—CDH1—salivary gland cancer	0.00695	0.0305	CbGpPWpGaD
Lenalidomide—CDH5—S1P2 pathway—PIK3CA—salivary gland cancer	0.00689	0.0302	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—SLC25A3—salivary gland cancer	0.00675	0.0296	CbGpPWpGaD
Lenalidomide—ABCB1—epithelium—salivary gland cancer	0.00594	0.00769	CbGeAlD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—MAP2K2—salivary gland cancer	0.00594	0.026	CbGpPWpGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—PIK3CA—salivary gland cancer	0.00566	0.0248	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—MAP2K2—salivary gland cancer	0.0056	0.0246	CbGpPWpGaD
Lenalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—salivary gland cancer	0.00558	0.0244	CbGpPWpGaD
Lenalidomide—CDH5—Cell junction organization—CDH1—salivary gland cancer	0.00526	0.0231	CbGpPWpGaD
Lenalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—salivary gland cancer	0.00474	0.0208	CbGpPWpGaD
Lenalidomide—ABCB1—lymphoid tissue—salivary gland cancer	0.00457	0.00593	CbGeAlD
Lenalidomide—PTGS2—lymph node—salivary gland cancer	0.00417	0.00541	CbGeAlD
Lenalidomide—CDH5—Cell-Cell communication—CDH1—salivary gland cancer	0.00375	0.0164	CbGpPWpGaD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—salivary gland cancer	0.00319	0.014	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00305	0.0134	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.0028	0.0123	CbGpPWpGaD
Lenalidomide—ABCB1—lymph node—salivary gland cancer	0.00258	0.00334	CbGeAlD
Lenalidomide—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00239	0.0105	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—PIK3CA—salivary gland cancer	0.00222	0.00973	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—PIK3CA—salivary gland cancer	0.0021	0.00919	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—HRAS—salivary gland cancer	0.00206	0.00901	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—WNT5B—salivary gland cancer	0.00204	0.00893	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL17RD—salivary gland cancer	0.00197	0.00863	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—MYB—salivary gland cancer	0.00196	0.00859	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—HRAS—salivary gland cancer	0.00194	0.0085	CbGpPWpGaD
Lenalidomide—CDH5—Cell-Cell communication—PIK3CA—salivary gland cancer	0.0019	0.00833	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAML3—salivary gland cancer	0.0018	0.00789	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—AQP1—salivary gland cancer	0.00179	0.00784	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MC3R—salivary gland cancer	0.0016	0.00703	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00154	0.00677	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—VCAN—salivary gland cancer	0.00141	0.00617	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—DTX4—salivary gland cancer	0.0014	0.00615	CbGpPWpGaD
Lenalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.0013	0.00569	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FGF16—salivary gland cancer	0.00116	0.00508	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAML2—salivary gland cancer	0.00101	0.00442	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FOXO3—salivary gland cancer	0.000907	0.00397	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—JAG1—salivary gland cancer	0.00086	0.00377	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FGFR4—salivary gland cancer	0.000857	0.00375	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FBXW7—salivary gland cancer	0.000843	0.00369	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.0008	0.0035	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000796	0.00349	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000746	0.00327	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.000722	0.00316	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FOXO3—salivary gland cancer	0.000711	0.00312	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.000709	0.00311	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000639	0.0028	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.000621	0.00272	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAP2K2—salivary gland cancer	0.000581	0.00254	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.000567	0.00248	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000545	0.00239	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CCND1—salivary gland cancer	0.000534	0.00234	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—EP300—salivary gland cancer	0.000492	0.00215	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NOTCH1—salivary gland cancer	0.000476	0.00208	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000453	0.00199	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CREBBP—salivary gland cancer	0.000431	0.00189	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000431	0.00189	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000423	0.00185	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ISYNA1—salivary gland cancer	0.000419	0.00184	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCND1—salivary gland cancer	0.000407	0.00178	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—WNT5B—salivary gland cancer	0.000393	0.00172	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL17RD—salivary gland cancer	0.000379	0.00166	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CPSF4—salivary gland cancer	0.000379	0.00166	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PYGB—salivary gland cancer	0.000379	0.00166	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000374	0.00164	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAML3—salivary gland cancer	0.000347	0.00152	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000343	0.0015	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MARCKS—salivary gland cancer	0.000342	0.0015	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.000337	0.00147	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCND1—salivary gland cancer	0.000319	0.0014	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PYGB—salivary gland cancer	0.000318	0.00139	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PTEN—salivary gland cancer	0.000308	0.00135	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000305	0.00134	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.000298	0.0013	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000297	0.0013	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EP300—salivary gland cancer	0.000294	0.00129	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000277	0.00121	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000272	0.00119	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—DTX4—salivary gland cancer	0.00027	0.00118	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.000268	0.00117	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000267	0.00117	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000265	0.00116	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000259	0.00113	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000255	0.00112	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000249	0.00109	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000242	0.00106	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000226	0.000992	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000225	0.000987	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGF16—salivary gland cancer	0.000224	0.000979	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PIK3CA—salivary gland cancer	0.000217	0.000952	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NUP62—salivary gland cancer	0.000214	0.000939	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—VCAN—salivary gland cancer	0.000213	0.000932	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TP53—salivary gland cancer	0.00021	0.000921	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HRAS—salivary gland cancer	0.000201	0.000881	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000196	0.00086	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAML2—salivary gland cancer	0.000194	0.000851	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000189	0.00083	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000189	0.000826	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000184	0.000804	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000182	0.000799	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000181	0.000792	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NUP62—salivary gland cancer	0.000179	0.000786	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—VCAN—salivary gland cancer	0.000178	0.00078	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000177	0.000774	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—JAG1—salivary gland cancer	0.000166	0.000726	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGFR4—salivary gland cancer	0.000165	0.000723	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FBXW7—salivary gland cancer	0.000162	0.000712	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AQP1—salivary gland cancer	0.00016	0.000703	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000156	0.000685	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FOXO3—salivary gland cancer	0.000137	0.0006	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000134	0.000586	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000129	0.000567	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000127	0.000557	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000126	0.000553	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAP2K2—salivary gland cancer	0.000112	0.00049	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000112	0.000489	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000106	0.000466	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000105	0.000462	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOTCH1—salivary gland cancer	9.16e-05	0.000402	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CREBBP—salivary gland cancer	8.31e-05	0.000364	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.87e-05	0.000345	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CREBBP—salivary gland cancer	6.96e-05	0.000305	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PTEN—salivary gland cancer	5.93e-05	0.00026	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EP300—salivary gland cancer	5.66e-05	0.000248	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PTEN—salivary gland cancer	4.97e-05	0.000218	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CREBBP—salivary gland cancer	4.93e-05	0.000216	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—EP300—salivary gland cancer	4.74e-05	0.000208	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3CA—salivary gland cancer	4.19e-05	0.000183	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HRAS—salivary gland cancer	3.87e-05	0.00017	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTEN—salivary gland cancer	3.52e-05	0.000154	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CA—salivary gland cancer	3.51e-05	0.000154	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—EP300—salivary gland cancer	3.36e-05	0.000147	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.49e-05	0.000109	CbGpPWpGaD
